表紙
市場調査レポート

冠動脈疾患 (CAD):世界の治験レビュー

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 240579
出版日 ページ情報 英文 100 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
冠動脈疾患 (CAD):世界の治験レビュー Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014
出版日: 2014年08月30日 ページ情報: 英文 100 Pages
概要

当レポートでは、世界の冠動脈疾患 (CAD)治療薬の臨床試験について調査し、 地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 冠動脈疾患 (CAD)
    • レポートガイダンス
  • 臨床試験: 地域別
  • 臨床試験: 国別
    • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要5ヵ国 − 中東およびアフリカ
    • 臨床試験に寄与している主要5ヵ国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験: 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要: 主要企業
      • Abbott Laboratories
      • Boston Scientific Corporation
      • Cordis Corporation
      • Medtronic, Inc.
      • Johnson & Johnson
      • AstraZeneca PLC
      • GE Healthcare
      • Pfizer Inc.
      • Gilead Sciences, Inc.
      • Eli Lilly and Company
      • POINT Biomedical Corporation
      • Sahajanand Medical Technologies Pvt. Ltd.
      • Lantheus Medical Imaging, Inc.
      • アステラス製薬
      • Cook
      • Bracco Diagnostics, Inc.
      • Sanofi
      • Intermountain Healthcare, Inc.
      • Forest Laboratories, Inc.
      • 小野薬品工業
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • Seoul National University Hospital
      • Sapienza University of Rome
      • University of Ottawa Heart Institute
      • Yonsei University
      • 熊本大学
      • Emory University
      • University Hospital Inselspital, Berne
      • Norwegian University of Science and Technology
      • National Taiwan University Hospital
      • MedStar Health Research Institute
      • 京都大学
      • Samsung Medical Center
      • University of Sao Paulo
      • Deutsches Herzzentrum Munchen
      • Mayo Clinic
      • Oslo University Hospital
      • University of Leipzig
      • Massachusetts General Hospital
      • Skejby Hospital
      • Montreal Heart Institute Research Centre
  • 5つの主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2014" provides data on the Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Artery Disease (CAD) (Ischemic Heart Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Artery Disease (CAD) (Ischemic Heart Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Coronary Artery Disease (CAD) (Ischemic Heart Disease)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Coronary Artery Disease (CAD) (Ischemic Heart Disease)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Medtronic, Inc.
      • Clinical Trial Overview of Medtronic, Inc.
      • Boston Scientific Corporation
      • Clinical Trial Overview of Boston Scientific Corporation
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Yonsei University
      • Clinical Trial Overview of Yonsei University
      • Cardiovascular Research Foundation
      • Clinical Trial Overview of Cardiovascular Research Foundation
      • Kumamoto University
      • Clinical Trial Overview of Kumamoto University
      • University of Florida
      • Clinical Trial Overview of University of Florida
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Emory University
      • Clinical Trial Overview of Emory University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Kyoto University
      • Clinical Trial Overview of Kyoto University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific Corporation, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiovascular Research Foundation, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014*

List of Figures

  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top